Reports that the European Commission has banned GlaxoSmithKline's (GSK) dual drug pricing system in Spain. Information on the dual pricing system of GSK; Company's claim about dual pricing system; Reason for rejecting the dual pricing system in Spain....
Volume 749, 16 February 2025, Page 151352 Purchase options CorporateFor R&D professionals working in corporate organizations. Academic and personalFor academic or personal use only. Looking for a customized option? Contact sales for special pricing for your organizationContact sales ...
Volume 489, August 2024, Page 117019 Purchase options CorporateFor R&D professionals working in corporate organizations. Academic and personalFor academic or personal use only. Looking for a customized option? Contact sales for special pricing for your organizationContact sales ...
Purchase options CorporateFor R&D professionals working in corporate organizations. Academic and personalFor academic or personal use only. CliniciansFor doctors, nurses, and other medical professionals. Looking for a customized option? Contact sales for special pricing for your organizationContact sales ...
Volume 79, Issue 1, January 2011, Pages 91-105 Purchase options CorporateFor R&D professionals working in corporate organizations. Academic and personalFor academic or personal use only. Looking for a customized option? Contact sales for special pricing for your organizationContact sales ...
Amyotrophic lateral sclerosis Demyelination Methylmercury PI3K/Akt/mTOR/STAT-3/GSK-3β Neurodegeneration Neuroprotection 1. Introduction Amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig's disease, is a degenerative neurological disorder that gradually causes the deterioration of motor ...
Internal Revenue Service from 1989 to 1996. Investigation to be conducted on the drug profits posted by the company; Information on the transfer pricing scheme used by GSK; Claim made by the company.EBSCO_bspChemistry & Industry